Improving Infection Resistance in Tissue Engineered Scaffolds for Tensile Applications Using Vancomycin‐Embedded Melt Electrowritten Scaffolds

• Published in: Macromolecular materials and engineering 2023-10, Vol.308 (10), p.n/a
• Main Authors: Mathew, Asha, Devlin, Brenna L., Singh, Dilpreet, Paxton, Naomi C., Woodruff, Maria A.
• Format: Article
• Language: English
• Subjects: 3-D printers; Antibacterial activity; Antibiotics; Antimicrobial agents; Biological properties; Biomechanics; Biomedical materials; Cell adhesion; Controlled release; Drug delivery systems; Drug dosages; drug encapsulation and release; Evaporation; Geometry; Gram-positive bacteria; Infections; Investigations; Mechanical properties; melt electrowriting; PCL; Polycaprolactone; Pore size; Regeneration (physiology); Regenerative medicine; Reproducibility; Scaffolds; Sustained release; Tissue engineering; Transplants & implants; Vancomycin; Yield stress
• ISSN: 1438-7492; 1439-2054
• DOI: 10.1002/mame.202300168

It is important to consider mechanical, biological, and antibacterial properties of scaffolds when used for tissue engineering applications. This study presents a method to create complex “wavy” architecture polycaprolactone (PCL) scaffolds toward the development of tissue engineered ligament and tendon tissue substitutes, fabricated using melt electrowriting (MEW) and loaded with vancomycin (5, 10, and 25% w/w). Scaffolds are characterized for both mechanical and biological properties. Loading PCL scaffolds with vancomycin with modified solvent evaporation technique achieves a high loading efficiency of maximum 18% w/w and high encapsulation efficiency with over 89%. Vancomycin loaded PCL scaffolds with all three doses (5, 10, and 25% w/w) display antibacterial activity against Gram‐positive Staphylococcus aureus (S. aureus) up to 14 days of release. Initial burst followed by a sustained release is observed on all three vancomycin loaded scaffolds for up to 28 days. Importantly, in addition to antibacterial properties, vancomycin‐loaded PCL scaffolds also display improved mechanical properties compared to traditional crosshatch design MEW scaffolds and are noncytotoxic at all concentrations as demonstrated by live‐dead staining, cell attachment and proliferation assays indicating its potential as an effective treatment option for tissue regeneration in rotator cuff injuries or other tissues undergoing tensile biomechanical loading.